TORL BioTherapeutics
About:
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
Website: https://torlbio.com
Top Investors: Blue Owl, Alexandria Venture Investments, RA Capital Management, Bristol-Myers Squibb, Goldman Sachs
Description:
TORL BioTherapeutics is a clinical-stage biopharmaceutical business focused on creating innovative, antibody-based medicines to improve the lives of cancer patients. They are developing a comprehensive pipeline of innovative preclinical ADCs and mAb in oncologic diseases with high unmet medical needs.
Total Funding Amount:
$316M
Headquarters Location:
Culver City, California, United States
Founded Date:
2018-01-01
Contact Email:
info(AT)torlbio.com
Founders:
Number of Employees:
Last Funding Date:
2024-04-10
IPO Status:
Private
© 2025 bioDAO.ai